Monoamine uptake inhibitors attenuate ethanol intake in alcohol-preferring (P) rats.
The P line of alcohol-preferring rats drink pharmacologically significant amounts of ethanol when given free choice between a 10 percent ethanol solution and water. Serotonin (5-HT) uptake inhibitors and desipramine, a norepinephrine (NE) uptake inhibitor, were found to significantly reduce their ethanol consumption for up to 24 hours after intraperitoneal injection. To determine if this effect of 5-HT uptake inhibitors could be altered by receptor antagonists, some of which are short acting, P rats were trained to drink ethanol by free choice during scheduled availability, with ethanol being presented one hour every four hours during the light cycle. The majority of the ethanol was consumed during the first hour of availability, and the ethanol intake was significantly reduced by the 5-HT uptake inhibitors, fluoxetine and fluvoxamine. Pretreatment with antagonists for 5-HT1, 5-HT2 and alpha- and beta-NE receptor systems failed to alter the fluvoxamine attenuation of ethanol intake. The mechanism by which 5-HT uptake inhibitors alter ethanol preference remains unclear.
D000428:Alcohol Drinking; D000818:Animals; D001921:Brain / Q000187:drug effects; D003891:Desipramine / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology; D005473:Fluoxetine / Q000494:pharmacology*; D016666:Fluvoxamine; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D010091:Oximes / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000502:physiology
D004873:Ergolines; D010091:Oximes; D011437:Propylamines; D005473:Fluoxetine; D012701:Serotonin; D011433:Propranolol; C032663:LY 53857; D016666:Fluvoxamine; D003891:Desipramine; D009638:Norepinephrine; D008784:Methysergide; D010646:Phentolamine